Delivery Order SPE2DB24D2101-SPE2DB25FKLXB

Award Date 7/1/25
Potential Completion Date 7/2/25
Potential Value $29K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,035.48 firm fixed price delivery order is for the supply of NEULASTA 6 MG/0.6 ML SYRINGE 0.6ML, a specialty medication, with a performance period through April 2025. The contract is not designated with a set-aside and represents open competition. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,043.64, is for the delivery of Neulasta OnPro 6 mg/0.6 ml kits, a specialty medication used in the treatment of certain medical conditions. The contract is a firm fixed-price delivery order with a completion date of March 12, 2024. This award is not designated as a set-aside contract....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Neulasta OnPro 6 mg/0.6 ml kits, a medication used to reduce the risk of infection in cancer patients undergoing chemotherapy. The contract has a ceiling value of $13,074.00 and a completion date of July 10, 2025. It is a firm fixed-price contract, which indicates the price is...
This is a $2,465.76 firm-fixed price delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Neulasta OnPro 6 mg/0.6 ml kits. The order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's global military treatment programs and...
This federal contract award is for the pharmaceutical product Neupogen 480 mcg/0.8 mL syringe, awarded to the prime contractor Amerisourcebergen Drug Corp. The $2,482.88 firm fixed price delivery order has an ultimate completion date of November 22, 2024. The contract was awarded on November 21, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency supplying medical products to military treatment facilities and veterans' healthcare programs. Amerisourcebergen, a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NEMLUVIO 30 MG PENS, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $1,929.20 and a period of performance ending on July 29, 2025. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,209.00 and a period of performance ending on April 11, 2025. The contract is not set aside and allows Amerisourcebergen Drug Corp to supply a wide range of pharmaceutical products and medical supplies, including medications across various therapeutic domains such as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Prolia 60 mg/ml syringes. The contract has a ceiling value of $8,828.08 and is a firm fixed-price, non-set-aside contract with a performance period through May 6, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of a range of pharmaceutical products and medical supplies. The contract has a ceiling value of $46,314.50 and a performance period through July 1, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of a variety of pharmaceutical products and medical supplies. The contract has a ceiling value of $18,419.82 and a period of performance through June 10, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB25FKLXB
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Neulasta 6 mg/0.6 ml syringes. The contract has a ceiling value of $29,497.72 and a period of performance through July 2, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is not designated as a set-aside contract, indicating open competition. The contract supports the federal government's medical procurement needs, particularly for military and veteran healthcare systems.

Generated 9/30/25, 9:54 AM